Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain

ADELAIDE, AUS, Oct 19, 2021 – (ACN Newswire) – Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the news that its client XWPharma Ltd. has announced dosing of subjects in its first-in-human study evaluating XW10508, the Company’s novel, patented, glutamatergic NMDA antagonist and AMPA activator in development as an oral, once-daily therapy for... » read more

Hitachi, Tohoku University and Kyoto University Become World’s First to Establish Technology for Highly Efficient, High-quality Production of Actinium-225, a Material Required for Internal Radiation Therapy Called TAT
Hitachi, Tohoku University and Kyoto University Become World’s First to Establish Technology for Highly Efficient, High-quality Production of Actinium-225, a Material Required for Internal Radiation Therapy Called TAT

TOKYO, Oct 19, 2021 – (JCN Newswire via SEAPRWire.com) – Hitachi, Ltd. (TSE: 6501), Tohoku University and Kyoto University have become the world’s first (1) to establish technology for the highly efficient and high-quality production of actinium-225 (225Ac), a substance required for a form of radiation therapy known as targeted alpha therapy (TAT). TAT is... » read more

Lucid and Cross Marketing Co. Ltd. partner on ‘Global QiQUMO’
Lucid and Cross Marketing Co. Ltd. partner on ‘Global QiQUMO’

TOKYO, Sep 14, 2021 – (JCN Newswire via SEAPRWire.com) – Global programmatic research technology company Lucid has partnered with Cross Marketing Co. Ltd. to expand the reach of their self-service survey platform through the launch of ‘Global QiQUMO’. The partnership enables Global QiQUMO users in Japan to access online survey respondents in a variety of... » read more

TANAKA Memorial Foundation to Offer Precious Metals Research Grants of up to 5 Million Yen

TOKYO, Sep 1, 2021 – (JCN Newswire via SEAPRWire.com) – The TANAKA Memorial Foundation (Representative Director: Hideya Okamoto) announced that it will take applications for research themes for FY2021 Precious Metals Research Grants between September 1 (Wed) and November 30 (Tue). Applications will be accepted from Japanese educational institutions and public research institutes conducting research... » read more

Ev Dynamics Sponsors Poly U Ammonia-Powered Vehicle Research Project
Ev Dynamics Sponsors Poly U Ammonia-Powered Vehicle Research Project

HONG KONG, Aug 18, 2021 – (ACN Newswire via SEAPRWire.com) – Ev Dynamics (Holdings) Limited (the “Company”, Stock Code: 476, together with its subsidiaries, collectively “Ev Dynamics” or the “Group”), a provider of new energy vehicles and technology integrated solutions, is pleased to sponsor The Hong Kong Polytechnic University (“Poly U”) to carry out its... » read more

Avance Clinical Appoints Asia Biotech Specialist to Support APAC Growth
Avance Clinical Appoints Asia Biotech Specialist to Support APAC Growth

ADELAIDE, AUS, June 28, 2021 – (ACN Newswire) – Avance Clinical, the leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, announced the appointment of Andy Hu as Business Development Manager APAC, to support increasing biotech clinical trial demand from the region. Andy Hu Formerly with Informa Pharma Intelligence, the international biopharma... » read more

Avance Clinical’s USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities
Avance Clinical’s USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities

ADELAIDE, AUS, Jun 4, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as part of their presence at BIO Digital 2021. Results from the survey... » read more

Two Products of Zhaoke Ophthalmology (6622.HK) Passed The On-Site Inspection for Drug Registration of The National Medical Products Administration and The GMP Compliance Inspection of The Guangdong Medical Products Administration

HONG KONG, May 24, 2021 – (ACN Newswire via SEAPRWire.com) – Zhaoke Ophthalmology Limited (“Zhaoke Ophthalmology” or the “Company”; stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs, announced that on 13 May 2021, two pharmaceutical products of the Company, namely Bimatoprost... » read more

Agilex Biolabs’ Toxicology Tapped for SARS-CoV-2 Vaccine Research
Agilex Biolabs’ Toxicology Tapped for SARS-CoV-2 Vaccine Research

ADELAIDE, AUS, May 17, 2021 – (ACN Newswire via SEAPRWire.com) – Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, said biotechs with first-in-human studies can leverage significant quality, speed and cost advantages working with their company TetraQ toxicology for pre-clinical research in Australia. TetraQ is a NATA-accredited, GLP-recognised rodent... » read more

Eisai and National Cancer Center Commence Joint Research and Development Project
Eisai and National Cancer Center Commence Joint Research and Development Project

TOKYO, May 14, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and the National Cancer Center Japan announced today that both parties have entered into a joint research and development (R&D) agreement concerning “Basic research on the drug discovery and development to accelerate development of anticancer drugs in treatment of patients with rare... » read more

RIKEN, Fujitsu Launch Collaborative R&D Center in Japan in First Step Toward Realization of Superconducting Quantum Computers
RIKEN, Fujitsu Launch Collaborative R&D Center in Japan in First Step Toward Realization of Superconducting Quantum Computers

TOKYO, Apr 1, 2021 – (JCN Newswire via SEAPRWire.com) – RIKEN and Fujitsu today announced the opening of the “RIKEN RQC-Fujitsu Collaboration Center” to promote joint research and development of foundational technologies to put superconducting quantum computers into practical use. More specifically, Riken and Fujitsu will develop hardware and software technologies to realize a quantum... » read more

MHI Concludes Contract for France-Japan Joint Research Project to Enhance the Functionality of Autonomous Underwater Vehicles for Mine Countermeasures
MHI Concludes Contract for France-Japan Joint Research Project to Enhance the Functionality of Autonomous Underwater Vehicles for Mine Countermeasures

TOKYO, Mar 31, 2021 – (JCN Newswire via SEAPRWire.com) – Mitsubishi Heavy Industries, Ltd. (MHI) has concluded a research and prototype production contract with Japan’s Ministry of Defense for next-generation mine-countermeasure technology, a France-Japan joint research project being conducted based on agreement between defense authorities in the two countries. OZZ-5, autonomous underwater mine countermeasure vehicle... » read more

TANAKA Memorial Foundation Announces Recipients of Precious Metals Research Grants

TOKYO, Mar 31, 2021 – (ACN Newswire via SEAPRWire.com) – The TANAKA Memorial Foundation’s Representative Director, Hideya Okamoto, announced the recipients of the FY2020 Precious Metals Research Grants. Following a rigorous screening process, the Gold Awards, each for 2 million yen, were presented to Professor Yasushi Sekine and Professor Hideyuki Murakami, both of Waseda University.... » read more

Eisai Begins Construction of Its New Injection/Research Building at Kawashima Industrial Park in Japan
Eisai Begins Construction of Its New Injection/Research Building at Kawashima Industrial Park in Japan

TOKYO, Mar 22, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that, as part of one strategic investment towards the realization of its medium-term business plan “EWAY2025”, it has conducted the groundbreaking ceremony for the construction of a new injection/research building “Eisai Medicine Innovation Technology Solutions” (“EMITS”) at the Kawashima Industrial... » read more

DZNE and Eisai Enter Into Research Collaboration Agreement Aiming for Novel Drug Discovery for Neurodegenerative Disorders
DZNE and Eisai Enter Into Research Collaboration Agreement Aiming for Novel Drug Discovery for Neurodegenerative Disorders

TOKYO, Mar 17, 2021 – (JCN Newswire via SEAPRWire.com) – Deutsches Zentrum fur Neurodegenerative Erkrankungen and Eisai Co., Ltd. today announced that both parties have entered into a research collaboration agreement aiming to create potential novel treatments for neurodegenerative disorders including Alzheimer’s disease (AD) which modulate immune competence in neurons and glia cells. DZNE is... » read more

Fujitsu and RIKEN Complete Joint Development of Japan’s Fugaku, the World’s Fastest Supercomputer
Fujitsu and RIKEN Complete Joint Development of Japan’s Fugaku, the World’s Fastest Supercomputer

TOKYO, Mar 9, 2021 – (JCN Newswire via SEAPRWire.com) – 1. Overview Fugaku is Japan’s supercomputer that has been developed as a core system for the innovative High-Performance Computing Infrastructure (HPCI) promoted by Japan’s Ministry of Education, Culture, Sports, Science and Technology (MEXT). In 2014, RIKEN and Fujitsu began joint development of Fugaku and completed... » read more

Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Milestones
Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Milestones

ADELAIDE, AU, Feb 26, 2021 – (ACN Newswire) – The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical continues to celebrate their strategic partnership with Medidata, and the accreditation of seven Medidata inhouse experts. The two organizations have been working together to deliver world-class clinical research... » read more

Suntrap Discovered ‘LeSoleil’ for COVID-19 and the Epidemic
Suntrap Discovered ‘LeSoleil’ for COVID-19 and the Epidemic

Guangzhou, China, Feb 14, 2021 – (ACN Newswire) – AI-assisted computing has greatly improved the efficiency of new drug research and development. Suntrap Life Technologies Co., Ltd has taken the lead to establish the Suntrap IDDNU(R) platform to serve as an international drug discovery network alliance. In 2019, Suntrap Life Technologies established a drug research... » read more